載入...
Taming Neonatal Hypoxic-Ischemic Brain Injury by Intranasal Delivery of Plasminogen Activator Inhibitor-1
BACKGROUND AND PURPOSE: Plasminogen Activator Inhibitor-I (PAI-1), a ~50 kDa serine protease inhibitor, markedly reduces the extravascular toxicity of tissue-type plasminogen activator (tPA) in experimental hypoxic-ischemic (HI) brain injury of newborns. However, the current treatment with PAI-1 req...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4021397/ https://ncbi.nlm.nih.gov/pubmed/23881953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.113.001233 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|